SynthesisThoracic cancer2021

The role of EGFR-TKIs as adjuvant therapy in EGFR mutation-positive early-stage NSCLC: A meta-analysis.

Chutong Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.